Pregled bibliografske jedinice broj: 1057341
Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?
Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? // Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14 (2020), 4; 355-356 doi:10.1016/j.dsx.2020.04.014 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1057341 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Case report of chloroquine therapy and
hypoglycaemia in type 1 diabetes: What should
we
have in mind during the COVID-19 pandemic?
Autori
Baretić, Maja
Izvornik
Diabetes & Metabolic Syndrome: Clinical Research & Reviews (1871-4021) 14
(2020), 4;
355-356
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Chloroquine ; Type 1 diabetes ; Immunomodulatory effects ; Hypoglicaemia
Sažetak
A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID- 19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Maja Baretić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus
- MEDLINE
